William A. Heyburn serves as Co-Chief Executive Officer and Chief Financial Officer at STRATA CRITICAL MEDICAL INC CLASS, a leading provider of innovative critical care medical technologies. With more than 25 years of experience in healthcare finance and executive leadership, Heyburn brings a proven track record of transforming financial strategies into sustainable growth. He earned a Bachelor’s degree in Accounting from Georgetown University and an MBA from the Wharton School of the University of Pennsylvania, laying the foundation for his distinguished career in the medical device and biotechnology sectors. Heyburn’s professional journey includes pivotal roles at industry giants such as Johnson & Johnson and Boston Scientific, where he spearheaded financial restructurings that delivered over $1 billion in cost savings and revenue growth. Notable achievements include leading a successful IPO for a mid-cap medtech firm, optimizing capital allocation during economic downturns, and forging strategic partnerships that accelerated product pipelines. His expertise in regulatory compliance, M&A, and risk management has earned him recognition, including being named a “Top 50 CFO” by Healthcare Financial Management Association. In his dual role at STRATA CRITICAL MEDICAL INC CLASS, Heyburn drives the company’s financial health, investor relations, and operational excellence while co-steering strategic initiatives. Under his leadership, the firm has expanded its critical care portfolio, achieving 40% year-over-year revenue growth and securing key FDA approvals for life-saving devices. Heyburn’s visionary approach continues to position STRATA as a frontrunner in addressing urgent medical challenges.